Point72 Asset Management
AURA icon

Point72 Asset Management’s Aura Biosciences AURA Stock Holding History

Point72 Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
17,864
-3,844
-18% -$27.5K ﹤0.01% 3659
2026
Q1 		$145K Sell
21,708
-32,984
-60% -$189K ﹤0.01% 3573
2025
Q4 		$298K Buy
+54,692
New +$325K ﹤0.01% 3476

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Point72 Asset Management's AURA Position: Q2 2026 in Review

Point72 Asset Management reduced its Aura Biosciences (AURA) stake by 18% in Q2 2026, selling an estimated $27.5K and leaving 17,864 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3659.

Point72 Asset Management first reported a position in AURA in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q4 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Point72 Asset Management held 17,864 shares of Aura Biosciences worth $127K as of Q2 2026.
  • Point72 Asset Management sold 3,844 Aura Biosciences shares in Q2 2026, an estimated $27.5K.
  • Aura Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3659 holding.
  • Point72 Asset Management first reported a position in Aura Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Point72 Asset Management's Aura Biosciences position peaked at $298K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.